Cannabis Sativa Inc is a publicly traded company listed as OTCQB:CBDS, operating in the Telehealth and Hemp & CBD Consumer Goods sectors. The company has been an innovator and first mover in the Telehealth sector, offering HIPAA and HITECH compliant online physician cannabis recommendation services through its subsidiary PrestoDoctor. With a focus on branding and marketing high-quality cannabis products, Cannabis Sativa Inc is poised to shape the future of legal cannabis and industrial hemp products.

Cannabis Sativa Inc achieved significant milestones in its history, such as being awarded Patent PP27,475 for the Cannabis Plant named Ecuadorian Sativa, known as 'CTA'. This patent has opened new research opportunities for the company. Additionally, the company was granted Patent 10105343 for 'Cannabis based compositions and methods of treating hypertension' Marijuana Lozenge on October 23, 2018. These patents have marked important advancements in the company's intellectual property portfolio.

Cannabis Sativa Inc has been involved in notable projects such as the development and marketing of patented cannabis strains like 'CTA' and cannabis-based compositions for treating hypertension. These projects have showcased the company's expertise in the cannabis industry and its dedication to innovation. The successful acquisition of patents and licenses further demonstrates the company's strategic approach to intellectual property development and research.

Key events for Cannabis Sativa Inc include being awarded Patent PP27,475 for the Cannabis Plant 'CTA' and Patent 10105343 for 'Cannabis based compositions and methods of treating hypertension' Marijuana Lozenge. These patents represent significant achievements for the company in terms of intellectual property development and research. Additionally, the company's presence in the Telehealth sector and its innovative approach to online physician cannabis recommendation services highlight its commitment to providing quality services to consumers and businesses.